Developer docs
API playgroundTry for free, no card

Search company profiles

Copan Diagnostics

Full company profile

uuid0000w7f

Namestring
Copan Diagnostics
Legal namestring
Copan Diagnostics Inc.
Websiteurl
copanusa.com
Company typeenum
Private
Founded yearint
1979
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMurrieta, United States
HQ citystring
Murrieta
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
specimen collection devices, flocked swab technology, microbiology laboratory automation, AI digital microbiology, automated colony picking
Industry2 codes
PRIMARYHLAAAJAE
Automation, Controls & Manufacturing Execution for Bioprocessing (SCADA/DCS/PLC/MES)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAAAJAC
Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • Laboratory Apparatus & Furniture3821
Product category
Clinical Microbiology Laboratory Automation and Specimen Collection
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model5 records
1Laboratory Automation Instrument Sales
TypeHardware Sales
Description

Capital equipment revenue from WASP®, WASPLab®, WASP-FLO™, Colibrí™, Radian®, Collaborative Station, UriVerse™, and UniVerse® systems sold primarily to clinical microbiology laboratories. Includes related PhenoMATRIX® AI software licenses for cleared indications.

copanusa.com:443
2Specimen Collection & Transport Consumables
TypeSubscription Recurring
Description

Recurring revenue from FLOQSwabs®, CLASSIQSwabs™, ESwab®, UTM®, FecalSwab®, UriSponge®, eNAT®, MSwab®, Transystem™, SnotBuster™, and 4N6 FLOQSwabs® genetics and crime-scene devices. Consumables support both culture-based and molecular diagnostic workflows, creating a razor/blade dynamic with installed automation base.

copanusa.com:443
3LBM® Enrichment & Selective Broth Portfolio
TypeSubscription Recurring
Description

Recurring revenue from ready-to-use enrichment broths (GN Broth, Thiol Broth, BHI Broth, Selenite, LIM Broth, TSB Salt, and LBM® CABroth™) sold in automation-ready, shatterproof tubes. Distributed via Fisher Scientific and Beckman Coulter channels.

copanusa.com
4Customized Solutions & OEM/Private-Label Services
TypeLicensing Royalties
Description

Copan works with assay manufacturers, microbiome researchers, and at-home collection kit developers to create customized swabs and kits, including custom reagent filling into tubes — an OEM/private-label revenue stream complementary to its branded catalog.

copanusa.com
5Professional Services & Validation Support
TypeProfessional Services
Description

Implementation, training, and validation support bundled with FDA-cleared automation and AI platforms (e.g., PhenoMATRIX®, Colibrí™) for clinical laboratories adopting Copan's Full Laboratory Automation solutions.

prnewswire.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales
Pricing details1 tier
1Quote-based pricing; no public list price.
ModelOther
Notes

Pricing is not publicly disclosed on copanusa.com. Sales motion is driven via Contact Us forms, Request a Sample CTAs, and distributor channel pages for both instruments (WASP®, WASPLab®, Colibrí™) and consumables (FLOQSwabs®, ESwab®, FecalSwab®, enrichment broths).

copanusa.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 14 records shown
1FLOQSwabs®
Description

Patented Copan-invented flocked swabs for optimal sample collection and diagnostics across multiple sampling sites.

copanusa.com:443
+13 more records
Core offering1 text field

Copan Diagnostics manufactures and sells specimen collection, transport, and preservation devices (FLOQSwabs® flocked swabs, ESwab®, UTM®, FecalSwab®, eNAT®, UriSponge®, MSwab®, SnotBuster™, and LBM® enrichment broths), full laboratory automation systems (WASP® Walk-Away Specimen Processor, WASPLab®, UniVerse®/UriVerse™ aliquoting automation), FDA 510(k)-cleared AI image assessment software (PhenoMATRIX®), and an automated colony picking/workup instrument (Colibrí™). Its products are sold to clinical microbiology, hospital, public health, veterinary, forensic, and pharmaceutical/food safety laboratories through direct enterprise sales and scientific supply distributors (Fisher Scientific, Beckman Coulter).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • PhenoMATRIX® achieves up to 95.5% sensitivity for GBS detection vs 90.3% for manual reading — comparable to molecular methods (96.8%).
+4 more records
Product overview1 text field

Copan Diagnostics operates a portfolio organized around two integrated pillars: (1) specimen collection, transport, and preservation devices — anchored by the patented FLOQSwabs® flocked swabs invented in 1979 and the LBM® (Liquid-Based Microbiology) line (ESwab®, FecalSwab®, UTM®, eNAT®, MSwab®, UriSponge®, SnotBuster™, Transystem™) plus the LBM® Enrichment and Selective Broths portfolio (including the newest CABroth™ for Candida auris); and (2) microbiology laboratory automation and AI — anchored by the WASP®/WASPLab® full laboratory automation platform, the FDA 510(k)-cleared PhenoMATRIX® AI image-assessment software (with the PhenoMATRIX® TAG submodule), and the Colibrí™ automated colony picker/workup instrument. Supporting offerings include the UniVerse®/UriVerse™ specimen aliquoting line, the Radian® and Collaborative Station modules, and supplementary products for pharma & food safety (SRK®), forensics (4N6 FLOQSwabs® Crime Scene, NAO® Basket), and genetics (4N6FLOQSwabs®, hDNA Free FLOQSwabs®). Together the products form an end-to-end digital microbiology workflow from sample collection through automated streaking, incubation, AI-driven plate triage, colony picking, and ID/AST setup for downstream MALDI-TOF analyzers (bioMérieux VITEK® MS, Bruker MALDI Biotyper®) and AST systems (bioMérieux VITEK® 2, Beckman Coulter MicroScan).

Product and service23 records
1FLOQSwabs® Flocked Swabs
CategorySample collection device
Description

Patented original flocked swabs with nylon fibers sprayed perpendicularly onto the tip, enabling rapid sample uptake and >90% elution for bacteriology, rapid antigen testing, DFA, EIA, and molecular applications across nasopharyngeal, nasal, buccal/throat/oropharyngeal, skin, and surface sampling sites.

2CLASSIQSwabs™ Standard Fiber Wrapped Swabs
CategorySample collection device
Description

Traditional fiber-wrapped swabs offered alongside Copan's flocked portfolio for conventional specimen collection use cases.

3hDNA Free FLOQSwabs®
CategorySample collection device
Description

Human DNA-free flocked swabs designed for genetic and human identity applications requiring minimal host DNA contamination.

44N6 FLOQSwabs® Genetics
CategorySample collection device
Description

Flocked swabs engineered for forensic and genetic sample collection workflows.

5UTM® (Universal Transport Medium)
CategorySample transport system
Description

Viral transport medium used to preserve viruses, chlamydia, mycoplasma, and ureaplasma during transport from collection site to the testing laboratory for viral culture and molecular diagnostic applications.

6ESwab® Liquid-Based Collection and Transport System
CategoryLiquid-based microbiology transport
Description

Liquid-based multipurpose collection and transport system for microbiology specimens that enables both culture and molecular testing from a single collection device.

7FecalSwab®
CategoryLiquid-based microbiology transport
Description

Liquid-based collection, transport and processing system for enteric bacteria from fecal or rectal specimens, combining a Copan flocked swab with 2 mL of modified Cary-Blair medium, validated across culture, BD MAX™, BioFire FilmArray®, Seegene Allplex, Cepheid Xpert®, and Luminex GPP molecular workflows.

8UriSponge®
CategorySample transport system
Description

Boric acid-free urine specimen preservation and transport system designed to streamline modern laboratory workflows.

9SnotBuster™ Sputum Liquefying System
CategorySample processing device
Description

Sputum liquefying system for converting viscous sputum specimens into a liquid format suitable for downstream microbiology processing.

10eNAT® Molecular Specimen Transport System
CategoryMolecular specimen transport
Description

Sample collection and transport system that stabilizes and preserves nucleic acids for downstream molecular testing.

11MSwab® Molecular Assay Transport System
CategoryMolecular specimen transport
Description

Specimen collection and transport system designed for use with molecular assays.

12Transystem™ Traditional Bacteriology Transport
CategorySample transport system
Description

Traditional bacteriology transport system for maintaining viability of clinically relevant bacteria during transport.

13LBM® Enrichment and Selective Broths Portfolio
CategoryEnrichment and selective broths
Description

Ready-to-use, automation-ready selective enrichment broths in shatterproof tubes covering Salmonella/Shigella, Group B Streptococcus, fastidious bacteria, anaerobes, MRSA, enteric Gram-negative organisms, and Candida auris.

14LBM® CABroth™
CategoryEnrichment and selective broths
Description

Selective enrichment broth for Candida auris surveillance formulated as modified Sabouraud medium in 2 mL pre-aliquoted tubes, compatible with Copan eSwab®/FLOQSwabs® collection and WASP®/WASPLab® automation.

15WASP® Walk-Away Specimen Processor
CategoryMicrobiology laboratory automation
Description

Automated microbiology specimen processing system that performs front-end processing (planting and streaking) of culture plates, accepts any manufacturer's plated media, and serves as the entry point for the WASPLab® ecosystem.

16WASPLab® Full Laboratory Automation Platform
CategoryMicrobiology laboratory automation
Description

Modular, scalable, customizable full laboratory automation system for clinical microbiology that moves samples from front-end processing to smart incubation, digital microbiology imaging, and AI-driven plate reading, integrating PhenoMATRIX® AI and downstream Colibrí™ workup.

17PhenoMATRIX® AI Image Assessment Software
CategoryAI digital microbiology software
Description

AI-powered microbial colony image assessment software for WASPLab®, FDA 510(k)-cleared (K251511) as a Class II IVD, performing semi-quantitative and qualitative analysis of digital plate images using laboratory-defined expert rules and LIS-linked clinical context, with a TAG submodule for selecting optimal colonies for Colibrí™ picking.

18Colibrí™ Automated Colony Picking & Workup Instrument
CategoryAutomated ID/AST workup instrument
Description

Automated instrument for colony picking and preparation of targets for MALDI-TOF identification and McFarland bacterial suspensions for AST, with three FDA 510(k) clearances covering bioMérieux VITEK® MS, Bruker MALDI Biotyper®, VITEK® 2 AST, and Beckman Coulter MicroScan.

19UniVerse® Automated Specimen Preparation & Aliquoting Platform
CategorySpecimen aliquoting automation
Description

Automated platform for specimen preparation and aliquoting covering functionality, applications, benefits, compatibility, and technical specifications to enhance laboratory operations.

20UriVerse™ Automated Urine Specimen Aliquoting Solution
CategorySpecimen aliquoting automation
Description

Automated specimen aliquoting solution within Copan's specimen aliquoting automation line, targeted at urine specimen handling.

21CRYOBANK™ Bacterial Culture Freezing System
CategoryLaboratory supplies
Description

Bacterial culture freezing system used for cryopreservation and long-term storage of microbial isolates in laboratory workflows.

22SRK® Collection and Transport System
CategoryPharma and food safety collection
Description

Sample collection and transport system targeted at pharmaceutical and food safety microbiology applications.

234N6 FLOQSwabs® Crime Scene
CategoryForensic sample collection
Description

Flocked swabs designed for forensic crime scene sample collection.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership18 partners
Strategic tierStrategic Flagship Technology IntegrationTypeTechnology or Integration
Description

BioMérieux VITEK® MS mass spectrometry system is FDA-cleared for use with Copan's Colibrí™ automated specimen workup instrument. BioMérieux's CHROMID StreptoB chromogenic agar is referenced in PhenoMATRIX® validation studies. BioMérieux VITEK® 2 is FDA-cleared for Colibrí™-prepared McFarland suspensions for AST. BioMérieux BioFire FilmArray® GI Panel is paired with FecalSwab® in published clinical studies.

Strategic tierStrategic Flagship Technology IntegrationTypeTechnology or Integration
Description

Bruker MALDI Biotyper® CA mass spectrometry system is FDA-cleared for use with Copan's Colibrí™ automated workup instrument. Colibrí™ automatically seeds Bruker's target plate format, applies matrix, and sends instructions and coordinates for each workup spot, supporting microbial identification workflows.

3Beckman Coulter
Strategic tierStrategic Flagship Technology IntegrationTypeTechnology or Integration
Description

Beckman Coulter MicroScan AST system is FDA-cleared to receive McFarland suspensions prepared by Copan's Colibrí™. Beckman Coulter also serves as a distributor of Copan's LBM® Enrichment and Selective Broths portfolio via a dedicated distributor page.

copanusa.com
Strategic tierStrategic Flagship Technology IntegrationTypeTechnology or Integration
Description

Copan's FecalSwab® system has been validated by independent studies with the BD MAX™ molecular platform for enteric pathogen detection (Enteric Viral Panel and Enteric Bacterial Panel), with 100% agreement and equivalent sensitivity to BD's recommended Para-Pak® Cary-Blair medium. Validated across multiple peer-reviewed publications in the Journal of Clinical Microbiology.

Strategic tierMajor Validated IntegrationTypeTechnology or Integration
Description

BioFire's FilmArray® Gastrointestinal (GI) Panel has been validated for use with Copan's FecalSwab® across multiple peer-reviewed studies (Silbert et al. 2017, Chapin et al. 2016), enabling ~1-hour molecular results from Cary-Blair preserved FecalSwab® specimens.

Strategic tierParent Group AffiliateTypeStrategic or Co-development Partner
Description

Copan Italia S.p.A. is the parent/affiliate entity of Copan Diagnostics, Inc., identified in Copan Diagnostics' Privacy Policy as part of the Affiliates group; serves as the European/global headquarters of the Copan Group and supports manufacturing for non-Americas markets.

Strategic tierParent Group AffiliateTypeStrategic or Co-development Partner
Description

Copan Group – Copan Canada is identified as an Affiliate entity in Copan Diagnostics' Privacy Policy, supporting the company's Canadian laboratory customers and field sales operations.

Strategic tierKey Channel Distributor For ConsumablesTypeChannel Partner/ Reseller/ Distributor
Description

Fisher Scientific / Fisher Healthcare distributes Copan's LBM® Enrichment and Selective Broths (including CABroth™) and serves as a primary channel partner for Copan consumables in the U.S. market. Copan has exhibited at the Fisher Healthcare National Sales Meeting (e.g., booth #307 in 2016) for direct engagement with Fisher's sales force.

9Beckman Coulter (Distribution)
Strategic tierKey Channel Distributor For Enrichment BrothsTypeChannel Partner/ Reseller/ Distributor
Description

Beckman Coulter distributes Copan's LBM® Enrichment and Selective Broths portfolio via its microbiology channel, with a dedicated "Request to talk to Reps" page.

Strategic tierValidated IntegrationTypeTechnology or Integration
Description

Copan's FecalSwab® has been independently validated by Mashock et al. (JCM 2017) for use with the Cepheid Xpert C. difficile assay, demonstrating equivalent performance to unpreserved stool and enabling adoption on GeneXpert systems.

Strategic tierMarketing Technology VendorTypeGTM or Marketing Partner
Description

Salesforce Pardot is used by Copan as an Online Tool Provider / Tracking Technology for email marketing, lead capture, and marketing automation. Personal information may be shared with Pardot per the Privacy Policy.

Strategic tierMarketing/Content Technology IntegrationTypeTechnology or Integration
Description

Bioz powers Copan's Scientific Studies Library on copanusa.com, surfacing peer-reviewed publications, posters, and citations related to Copan products in real time. Bioz is also referenced as a Tracking Technology in the Privacy Policy.

13Google Analytics
Strategic tierMarketing Analytics VendorTypeTechnology or Integration
Description

Google Analytics is used by Copan as a Tracking Technology to measure, analyze, and report on access to and usage of copanusa.com; Google AdWords sensitive category restrictions apply.

copanusa.com
Strategic tierSeo/Marketing Analytics VendorTypeTechnology or Integration
Description

Semrush is used by Copan as a Tracking Technology for SEO and digital marketing analytics on copanusa.com.

Strategic tierMarketing/Social Media IntegrationTypeTechnology or Integration
Description

Meta Platforms is used by Copan as a Tracking Technology for cross-context advertising and audience targeting; copanusa.com links to Facebook social media presence.

Strategic tierValidated Integration In Fda ClearanceTypeTechnology or Integration
Description

CHROMagar Orientation plates are explicitly named in PhenoMATRIX®'s FDA 510(k) clearance (K251511) as a supported culture medium for AI-based image assessment of microbial growth.

17Fisher Healthcare Sales Organization
Strategic tierSales/Marketing CollaborationTypeGTM or Marketing Partner
Description

Copan engages with Fisher Healthcare's sales organization at events such as the National Sales Meeting at Gaylord Texan Resort & Convention Center, with booths, demos, and direct sales-force engagement to drive pull-through of Copan consumables such as FecalSwab®.

Strategic tierLegal/Dispute Resolution VendorTypeOthers
Description

JAMS is designated in Copan's Website Terms of Use as the arbitration organization that administers any disputes between users and Copan under the Binding Arbitration Provision.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Molecular diagnostics leader with GeneXpert systems including Xpert® C. difficile. Copan's FecalSwab® is independently validated for GeneXpert, positioning Cepheid as a molecular workflow competitor whose adoption could shift volumes away from culture-based workflows served by WASPLab®.

TypeBroad incumbent
Description

Owner of the MALDI Biotyper® mass spectrometry system, which is FDA-cleared for use with Copan's Colibrí™. Bruker also sells its own microbiology software and identification databases, creating a partial overlap in the ID/AST workflow where Copan operates.

TypeBroad incumbent
Description

Molecular diagnostics company with Panther and other molecular platforms serving women's health, infectious disease, and clinical labs. Adjacent competitor in molecular specimen transport where Copan's eNAT® and MSwab® compete for sample collection share.

4Beckman Coulter
TypeBroad incumbent
Description

Microbiology and clinical diagnostics incumbent with MicroScan AST system, DxM automation, and urine microscopy. Colibrí™ holds an FDA 510(k) for use with MicroScan, and Beckman Coulter also distributes Copan's LBM® enrichment broths — making it a hybrid channel partner and overlapping automation competitor.

TypeBroad incumbent
Description

Global leader in clinical microbiology with overlapping VITEK MS MALDI-TOF, VITEK 2 AST, and BioFire FilmArray molecular panels. Copan's Colibrí™ and PhenoMATRIX® are explicitly FDA-cleared to interoperate with bioMérieux instruments, making it both the most direct technology integration partner and the largest competitive incumbent.

TypeEmerging player
Description

Molecular sample preparation, transport, and assay vendor with overlapping eNAT-style nucleic acid preservation products and QIAcube automation. Overlaps with Copan's molecular specimen transport line and competes in pathogen detection workflows.

TypeDirect peer
Description

U.S. manufacturer of culture media, sample collection and transport devices, and microbiology laboratory supplies. Directly competes with Copan's FLOQSwabs®, ESwab®, and other transport consumables across clinical, food, and pharmaceutical microbiology labs.

TypeDirect peer
Description

U.S. manufacturer of specimen collection swabs, flocked swabs, and forensic/clinical transport devices. Direct competitor to Copan's FLOQSwabs® and CLASSIQSwabs™ in hospital, public health, and diagnostic lab channels.

TypeBroad incumbent
Description

Major diagnostics and life sciences company with BD MAX™ molecular platform and BD Kiestra™ laboratory automation, a direct competitor to WASPLab® in clinical microbiology. Copan's FecalSwab® and ESwab® consumables are validated on BD MAX™, positioning BD as both partner and competitor across collection and automation.

10Remel (Thermo Fisher Scientific)
TypeDirect peer
Description

Thermo Fisher's clinical microbiology brand, offering transport systems, culture media, and identification products that overlap with Copan's specimen collection and transport portfolio. Competes directly in hospital and reference lab consumables procurement.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration11 records

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Copan Diagnostics

Clinical Microbiology Laboratory Automation and Specimen Collectioncopanusa.com

Copan Diagnostics firmographics

Firmographics
Name
Copan Diagnostics
Legal name
Copan Diagnostics Inc.
Website
https://copanusa.com
Company type
Private
Founded year
1979
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

Copan Diagnostics industry classification

Industry
Product category
Clinical Microbiology Laboratory Automation and Specimen Collection
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Medical Equipment and Supplies Manufacturing (3391)
SIC
Laboratory Analytical Instruments (3826), Laboratory Apparatus & Furniture (3821)
akta.pro industry
PRIMARYHLAAAJAE
Automation, Controls & Manufacturing Execution for Bioprocessing (SCADA/DCS/PLC/MES)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAAAJAC
Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)

Keywords

  • Specimen collection devices
  • Flocked swab technology
  • Microbiology laboratory automation
  • AI digital microbiology
  • Automated colony picking

Where Copan Diagnostics is headquartered

Location

Headquarters

HQ city
Murrieta
HQ country
United States
HQ region
North America

Markets served

Copan Diagnostics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales

Revenue model

  1. Laboratory Automation Instrument Sales: Capital equipment revenue from WASP®, WASPLab®, WASP-FLO™, Colibrí™, Radian®, Collaborative Station, UriVerse™, and UniVerse® systems sold primarily to clinical microbiology laboratories. Includes related PhenoMATRIX® AI software licenses for cleared indications.
  2. Specimen Collection & Transport Consumables: Recurring revenue from FLOQSwabs®, CLASSIQSwabs™, ESwab®, UTM®, FecalSwab®, UriSponge®, eNAT®, MSwab®, Transystem™, SnotBuster™, and 4N6 FLOQSwabs® genetics and crime-scene devices. Consumables support both culture-based and molecular diagnostic workflows, creating a razor/blade dynamic with installed automation base.
  3. LBM® Enrichment & Selective Broth Portfolio: Recurring revenue from ready-to-use enrichment broths (GN Broth, Thiol Broth, BHI Broth, Selenite, LIM Broth, TSB Salt, and LBM® CABroth™) sold in automation-ready, shatterproof tubes. Distributed via Fisher Scientific and Beckman Coulter channels.
  4. Customized Solutions & OEM/Private-Label Services: Copan works with assay manufacturers, microbiome researchers, and at-home collection kit developers to create customized swabs and kits, including custom reagent filling into tubes — an OEM/private-label revenue stream complementary to its branded catalog.
  5. Professional Services & Validation Support: Implementation, training, and validation support bundled with FDA-cleared automation and AI platforms (e.g., PhenoMATRIX®, Colibrí™) for clinical laboratories adopting Copan's Full Laboratory Automation solutions.

Pricing tiers

ModelBillingPrice
Other—Quote-based pricing; no public list price.

Go-to-market motion4 records

Distribution channels6 records

Marketing channels10 records

Copan Diagnostics product offering

Product offering

Core offering

Copan Diagnostics manufactures and sells specimen collection, transport, and preservation devices (FLOQSwabs® flocked swabs, ESwab®, UTM®, FecalSwab®, eNAT®, UriSponge®, MSwab®, SnotBuster™, and LBM® enrichment broths), full laboratory automation systems (WASP® Walk-Away Specimen Processor, WASPLab®, UniVerse®/UriVerse™ aliquoting automation), FDA 510(k)-cleared AI image assessment software (PhenoMATRIX®), and an automated colony picking/workup instrument (Colibrí™). Its products are sold to clinical microbiology, hospital, public health, veterinary, forensic, and pharmaceutical/food safety laboratories through direct enterprise sales and scientific supply distributors (Fisher Scientific, Beckman Coulter).

Product overview

Copan Diagnostics operates a portfolio organized around two integrated pillars: (1) specimen collection, transport, and preservation devices — anchored by the patented FLOQSwabs® flocked swabs invented in 1979 and the LBM® (Liquid-Based Microbiology) line (ESwab®, FecalSwab®, UTM®, eNAT®, MSwab®, UriSponge®, SnotBuster™, Transystem™) plus the LBM® Enrichment and Selective Broths portfolio (including the newest CABroth™ for Candida auris); and (2) microbiology laboratory automation and AI — anchored by the WASP®/WASPLab® full laboratory automation platform, the FDA 510(k)-cleared PhenoMATRIX® AI image-assessment software (with the PhenoMATRIX® TAG submodule), and the Colibrí™ automated colony picker/workup instrument. Supporting offerings include the UniVerse®/UriVerse™ specimen aliquoting line, the Radian® and Collaborative Station modules, and supplementary products for pharma & food safety (SRK®), forensics (4N6 FLOQSwabs® Crime Scene, NAO® Basket), and genetics (4N6FLOQSwabs®, hDNA Free FLOQSwabs®). Together the products form an end-to-end digital microbiology workflow from sample collection through automated streaking, incubation, AI-driven plate triage, colony picking, and ID/AST setup for downstream MALDI-TOF analyzers (bioMérieux VITEK® MS, Bruker MALDI Biotyper®) and AST systems (bioMérieux VITEK® 2, Beckman Coulter MicroScan).

Differentiator

Problem solved

Functional benefit

Brands

  • FLOQSwabs®: Patented Copan-invented flocked swabs for optimal sample collection and diagnostics across multiple sampling sites.
  • UTM® (Universal Transport Medium)
  • ESwab®
  • FecalSwab®
  • eNAT®
  • WASP® (Walk-Away Specimen Processor)
  • WASPLab®
  • PhenoMATRIX®
  • Colibrí™
  • UniVerse®
  • UriSponge®
  • CRYOBANK™
  • 4N6 FLOQSwabs®
  • LBM® CABroth™

Products and services

  • FLOQSwabs® Flocked Swabs Patented original flocked swabs with nylon fibers sprayed perpendicularly onto the tip, enabling rapid sample uptake and >90% elution for bacteriology, rapid antigen testing, DFA, EIA, and molecular applications across nasopharyngeal, nasal, buccal/throat/oropharyngeal, skin, and surface sampling sites.
  • CLASSIQSwabs™ Standard Fiber Wrapped Swabs Traditional fiber-wrapped swabs offered alongside Copan's flocked portfolio for conventional specimen collection use cases.
  • hDNA Free FLOQSwabs® Human DNA-free flocked swabs designed for genetic and human identity applications requiring minimal host DNA contamination.
  • 4N6 FLOQSwabs® Genetics Flocked swabs engineered for forensic and genetic sample collection workflows.
  • UTM® (Universal Transport Medium) Viral transport medium used to preserve viruses, chlamydia, mycoplasma, and ureaplasma during transport from collection site to the testing laboratory for viral culture and molecular diagnostic applications.
  • ESwab® Liquid-Based Collection and Transport System Liquid-based multipurpose collection and transport system for microbiology specimens that enables both culture and molecular testing from a single collection device.
  • FecalSwab® Liquid-based collection, transport and processing system for enteric bacteria from fecal or rectal specimens, combining a Copan flocked swab with 2 mL of modified Cary-Blair medium, validated across culture, BD MAX™, BioFire FilmArray®, Seegene Allplex, Cepheid Xpert®, and Luminex GPP molecular workflows.
  • UriSponge® Boric acid-free urine specimen preservation and transport system designed to streamline modern laboratory workflows.
  • SnotBuster™ Sputum Liquefying System Sputum liquefying system for converting viscous sputum specimens into a liquid format suitable for downstream microbiology processing.
  • eNAT® Molecular Specimen Transport System Sample collection and transport system that stabilizes and preserves nucleic acids for downstream molecular testing.
  • MSwab® Molecular Assay Transport System Specimen collection and transport system designed for use with molecular assays.
  • Transystem™ Traditional Bacteriology Transport Traditional bacteriology transport system for maintaining viability of clinically relevant bacteria during transport.
  • LBM® Enrichment and Selective Broths Portfolio Ready-to-use, automation-ready selective enrichment broths in shatterproof tubes covering Salmonella/Shigella, Group B Streptococcus, fastidious bacteria, anaerobes, MRSA, enteric Gram-negative organisms, and Candida auris.
  • LBM® CABroth™ Selective enrichment broth for Candida auris surveillance formulated as modified Sabouraud medium in 2 mL pre-aliquoted tubes, compatible with Copan eSwab®/FLOQSwabs® collection and WASP®/WASPLab® automation.
  • WASP® Walk-Away Specimen Processor Automated microbiology specimen processing system that performs front-end processing (planting and streaking) of culture plates, accepts any manufacturer's plated media, and serves as the entry point for the WASPLab® ecosystem.
  • WASPLab® Full Laboratory Automation Platform Modular, scalable, customizable full laboratory automation system for clinical microbiology that moves samples from front-end processing to smart incubation, digital microbiology imaging, and AI-driven plate reading, integrating PhenoMATRIX® AI and downstream Colibrí™ workup.
  • PhenoMATRIX® AI Image Assessment Software AI-powered microbial colony image assessment software for WASPLab®, FDA 510(k)-cleared (K251511) as a Class II IVD, performing semi-quantitative and qualitative analysis of digital plate images using laboratory-defined expert rules and LIS-linked clinical context, with a TAG submodule for selecting optimal colonies for Colibrí™ picking.
  • Colibrí™ Automated Colony Picking & Workup Instrument Automated instrument for colony picking and preparation of targets for MALDI-TOF identification and McFarland bacterial suspensions for AST, with three FDA 510(k) clearances covering bioMérieux VITEK® MS, Bruker MALDI Biotyper®, VITEK® 2 AST, and Beckman Coulter MicroScan.
  • UniVerse® Automated Specimen Preparation & Aliquoting Platform Automated platform for specimen preparation and aliquoting covering functionality, applications, benefits, compatibility, and technical specifications to enhance laboratory operations.
  • UriVerse™ Automated Urine Specimen Aliquoting Solution Automated specimen aliquoting solution within Copan's specimen aliquoting automation line, targeted at urine specimen handling.
  • CRYOBANK™ Bacterial Culture Freezing System Bacterial culture freezing system used for cryopreservation and long-term storage of microbial isolates in laboratory workflows.
  • SRK® Collection and Transport System Sample collection and transport system targeted at pharmaceutical and food safety microbiology applications.
  • 4N6 FLOQSwabs® Crime Scene Flocked swabs designed for forensic crime scene sample collection.

Quantifiable outcome

  • PhenoMATRIX® achieves up to 95.5% sensitivity for GBS detection vs 90.3% for manual reading — comparable to molecular methods (96.8%).
  • +4 more outcomes

Companies that use Copan Diagnostics

Customer profile

Named customers3 records

Segments7 records

Ideal customer profiles4 records

Copan Diagnostics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration11 records

AI capability8 records

Feature8 records

Copan Diagnostics partnerships and signals

Strategic signal

Partnerships

18 partnerships are on record, tiered strategic flagship technology integration, major validated integration, parent group affiliate, key channel distributor for consumables, key channel distributor for enrichment broths, validated integration, marketing technology vendor, marketing/content technology integration, marketing analytics vendor, seo/marketing analytics vendor, marketing/social media integration, validated integration in fda clearance, sales/marketing collaboration and legal/dispute resolution vendor.

  • bioMérieuxstrategic flagship technology integrationTechnology or IntegrationBioMérieux VITEK® MS mass spectrometry system is FDA-cleared for use with Copan's Colibrí™ automated specimen workup instrument. BioMérieux's CHROMID StreptoB chromogenic agar is referenced in PhenoMATRIX® validation studies. BioMérieux VITEK® 2 is FDA-cleared for Colibrí™-prepared McFarland suspensions for AST. BioMérieux BioFire FilmArray® GI Panel is paired with FecalSwab® in published clinical studies.
  • Brukerstrategic flagship technology integrationTechnology or IntegrationBruker MALDI Biotyper® CA mass spectrometry system is FDA-cleared for use with Copan's Colibrí™ automated workup instrument. Colibrí™ automatically seeds Bruker's target plate format, applies matrix, and sends instructions and coordinates for each workup spot, supporting microbial identification workflows.
  • Beckman Coulterstrategic flagship technology integrationTechnology or IntegrationBeckman Coulter MicroScan AST system is FDA-cleared to receive McFarland suspensions prepared by Copan's Colibrí™. Beckman Coulter also serves as a distributor of Copan's LBM® Enrichment and Selective Broths portfolio via a dedicated distributor page.
  • Becton Dickinson (BD)strategic flagship technology integrationTechnology or IntegrationCopan's FecalSwab® system has been validated by independent studies with the BD MAX™ molecular platform for enteric pathogen detection (Enteric Viral Panel and Enteric Bacterial Panel), with 100% agreement and equivalent sensitivity to BD's recommended Para-Pak® Cary-Blair medium. Validated across multiple peer-reviewed publications in the Journal of Clinical Microbiology.
  • BioFire (bioMérieux)major validated integrationTechnology or IntegrationBioFire's FilmArray® Gastrointestinal (GI) Panel has been validated for use with Copan's FecalSwab® across multiple peer-reviewed studies (Silbert et al. 2017, Chapin et al. 2016), enabling ~1-hour molecular results from Cary-Blair preserved FecalSwab® specimens.
  • Copan Italia S.p.A.parent group affiliateStrategic or Co-development PartnerCopan Italia S.p.A. is the parent/affiliate entity of Copan Diagnostics, Inc., identified in Copan Diagnostics' Privacy Policy as part of the Affiliates group; serves as the European/global headquarters of the Copan Group and supports manufacturing for non-Americas markets.
  • Copan Group – Copan Canadaparent group affiliateStrategic or Co-development PartnerCopan Group – Copan Canada is identified as an Affiliate entity in Copan Diagnostics' Privacy Policy, supporting the company's Canadian laboratory customers and field sales operations.
  • Fisher Healthcare (Fisher Scientific)key channel distributor for consumablesChannel Partner/ Reseller/ DistributorFisher Scientific / Fisher Healthcare distributes Copan's LBM® Enrichment and Selective Broths (including CABroth™) and serves as a primary channel partner for Copan consumables in the U.S. market. Copan has exhibited at the Fisher Healthcare National Sales Meeting (e.g., booth #307 in 2016) for direct engagement with Fisher's sales force.
  • Beckman Coulter (Distribution)key channel distributor for enrichment brothsChannel Partner/ Reseller/ DistributorBeckman Coulter distributes Copan's LBM® Enrichment and Selective Broths portfolio via its microbiology channel, with a dedicated "Request to talk to Reps" page.
  • Cepheidvalidated integrationTechnology or IntegrationCopan's FecalSwab® has been independently validated by Mashock et al. (JCM 2017) for use with the Cepheid Xpert C. difficile assay, demonstrating equivalent performance to unpreserved stool and enabling adoption on GeneXpert systems.
  • Salesforce Pardotmarketing technology vendorGTM or Marketing PartnerSalesforce Pardot is used by Copan as an Online Tool Provider / Tracking Technology for email marketing, lead capture, and marketing automation. Personal information may be shared with Pardot per the Privacy Policy.
  • Biozmarketing/content technology integrationTechnology or IntegrationBioz powers Copan's Scientific Studies Library on copanusa.com, surfacing peer-reviewed publications, posters, and citations related to Copan products in real time. Bioz is also referenced as a Tracking Technology in the Privacy Policy.
  • Google Analyticsmarketing analytics vendorTechnology or IntegrationGoogle Analytics is used by Copan as a Tracking Technology to measure, analyze, and report on access to and usage of copanusa.com; Google AdWords sensitive category restrictions apply.
  • Semrushseo/marketing analytics vendorTechnology or IntegrationSemrush is used by Copan as a Tracking Technology for SEO and digital marketing analytics on copanusa.com.
  • Meta Platforms (Facebook)marketing/social media integrationTechnology or IntegrationMeta Platforms is used by Copan as a Tracking Technology for cross-context advertising and audience targeting; copanusa.com links to Facebook social media presence.
  • bioMérieux (CHROMagar Orientation)validated integration in fda clearanceTechnology or IntegrationCHROMagar Orientation plates are explicitly named in PhenoMATRIX®'s FDA 510(k) clearance (K251511) as a supported culture medium for AI-based image assessment of microbial growth.
  • Fisher Healthcare Sales Organizationsales/marketing collaborationGTM or Marketing PartnerCopan engages with Fisher Healthcare's sales organization at events such as the National Sales Meeting at Gaylord Texan Resort & Convention Center, with booths, demos, and direct sales-force engagement to drive pull-through of Copan consumables such as FecalSwab®.
  • JAMS (Judicial Arbitration and Mediation Services)legal/dispute resolution vendorOthersJAMS is designated in Copan's Website Terms of Use as the arbitration organization that administers any disputes between users and Copan under the Binding Arbitration Provision.

Scale indicators7 records

Recent moves5 records

Expansion highlights6 records

Copan Diagnostics competitors and assessment

Company assessment

Emerging players

  • Cepheid (Danaher): Molecular diagnostics leader with GeneXpert systems including Xpert® C. difficile. Copan's FecalSwab® is independently validated for GeneXpert, positioning Cepheid as a molecular workflow competitor whose adoption could shift volumes away from culture-based workflows served by WASPLab®.
  • QIAGEN: Molecular sample preparation, transport, and assay vendor with overlapping eNAT-style nucleic acid preservation products and QIAcube automation. Overlaps with Copan's molecular specimen transport line and competes in pathogen detection workflows.

Broad incumbents

  • Bruker: Owner of the MALDI Biotyper® mass spectrometry system, which is FDA-cleared for use with Copan's Colibrí™. Bruker also sells its own microbiology software and identification databases, creating a partial overlap in the ID/AST workflow where Copan operates.
  • Hologic: Molecular diagnostics company with Panther and other molecular platforms serving women's health, infectious disease, and clinical labs. Adjacent competitor in molecular specimen transport where Copan's eNAT® and MSwab® compete for sample collection share.
  • Beckman Coulter: Microbiology and clinical diagnostics incumbent with MicroScan AST system, DxM automation, and urine microscopy. Colibrí™ holds an FDA 510(k) for use with MicroScan, and Beckman Coulter also distributes Copan's LBM® enrichment broths — making it a hybrid channel partner and overlapping automation competitor.
  • bioMérieux: Global leader in clinical microbiology with overlapping VITEK MS MALDI-TOF, VITEK 2 AST, and BioFire FilmArray molecular panels. Copan's Colibrí™ and PhenoMATRIX® are explicitly FDA-cleared to interoperate with bioMérieux instruments, making it both the most direct technology integration partner and the largest competitive incumbent.
  • Becton Dickinson (BD): Major diagnostics and life sciences company with BD MAX™ molecular platform and BD Kiestra™ laboratory automation, a direct competitor to WASPLab® in clinical microbiology. Copan's FecalSwab® and ESwab® consumables are validated on BD MAX™, positioning BD as both partner and competitor across collection and automation.

Direct peers

  • Hardy Diagnostics: U.S. manufacturer of culture media, sample collection and transport devices, and microbiology laboratory supplies. Directly competes with Copan's FLOQSwabs®, ESwab®, and other transport consumables across clinical, food, and pharmaceutical microbiology labs.
  • Puritan Medical Products: U.S. manufacturer of specimen collection swabs, flocked swabs, and forensic/clinical transport devices. Direct competitor to Copan's FLOQSwabs® and CLASSIQSwabs™ in hospital, public health, and diagnostic lab channels.
  • Remel (Thermo Fisher Scientific): Thermo Fisher's clinical microbiology brand, offering transport systems, culture media, and identification products that overlap with Copan's specimen collection and transport portfolio. Competes directly in hospital and reference lab consumables procurement.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Copan Diagnostics social profiles

Digital presence

Copan Diagnostics compliance and trust

Trust signal

Compliance4 records

Copan Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Copan Diagnostics leadership team

Management profile

Number of profiles

Profiles4 records

Copan Diagnostics subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Copan Diagnostics funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Copan Diagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Copan Diagnostics

What does Copan Diagnostics do?

Copan Diagnostics manufactures and sells specimen collection, transport, and preservation devices (FLOQSwabs® flocked swabs, ESwab®, UTM®, FecalSwab®, eNAT®, UriSponge®, MSwab®, SnotBuster™, and LBM® enrichment broths), full laboratory automation systems (WASP® Walk-Away Specimen Processor, WASPLab®, UniVerse®/UriVerse™ aliquoting automation), FDA 510(k)-cleared AI image assessment software (PhenoMATRIX®), and an automated colony picking/workup instrument (Colibrí™). Its products are sold to clinical microbiology, hospital, public health, veterinary, forensic, and pharmaceutical/food safety laboratories through direct enterprise sales and scientific supply distributors (Fisher Scientific, Beckman Coulter).

Is Copan Diagnostics a public or private company?

Copan Diagnostics is a private company. It is classified as corporate owned and is currently operating.

When was Copan Diagnostics founded?

Copan Diagnostics was founded in 1979. It employs 101 to 250 people.

Where is Copan Diagnostics based?

Copan Diagnostics is headquartered in Murrieta, United States, in the North America region.

How does Copan Diagnostics make money?

Five revenue lines are on record. Laboratory Automation Instrument Sales are the primary driver. The others are specimen Collection & Transport Consumables, LBM® Enrichment & Selective Broth Portfolio, customized Solutions & OEM/Private-Label Services and professional Services & Validation Support.

Who are Copan Diagnostics's main competitors?

Emerging players on record are Cepheid (Danaher) and QIAGEN. Broad incumbents are Bruker, Hologic, Beckman Coulter, bioMérieux and Becton Dickinson (BD). Direct peers are Hardy Diagnostics, Puritan Medical Products and Remel (Thermo Fisher Scientific).

Does Copan Diagnostics have an API?

No public API is recorded for Copan Diagnostics.

What industry is Copan Diagnostics in?

Copan Diagnostics's product category is Clinical Microbiology Laboratory Automation and Specimen Collection. Its primary akta.pro industry code is HLAAAJAE, Automation, Controls & Manufacturing Execution for Bioprocessing (SCADA/DCS/PLC/MES), with a secondary code of HLAAAJAC, Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Manufacturing TodayCopan stakes its future on domestic production growthCopan Diagnostics is investing over $7 million to expand its manufacturing capabilities in California and Puerto Rico, focusing on respiratory and urine specimen collection kits. This expansion aims to enhance domestic production and localization of supply chains, with operations set to begin in early 2026. The move is part of a broader trend of reshoring in manufacturing to improve supply chain resilience after the disruptions experienced during the pandemic.PR NewswireCopan Expands U.S. Manufacturing Footprint with Multimillion-Dollar InvestmentCopan Diagnostics, part of Italy-based Copan Group, announced a multimillion-dollar investment exceeding $5 million to expand U.S. manufacturing at its California and Puerto Rico facilities. The investment includes new production of UriSponge® devices, increased U.S. component and reagent sourcing, and a new centralized quality assurance laboratory, with construction beginning this month and operations projected to launch in Q1 2026. The expansion aims to reduce reliance on overseas supply chains and strengthen supply chain resilience for U.S. laboratories.PharmiWeb.comBioz and Copan Diagnostics Release AI-Based Citation Tools for ResearchersBioz and Copan Diagnostics announced AI-based citation tools for Copan's product and scientific studies pages. The tools include Bioz Badges and a Content Hub with over 16,000 citations, automatically updated via NLP. The tools aim to help customers evaluate product usage in scientific literature.NewswireCopan Diagnostics Announces Leadership ChangeCopan Diagnostics announced Norman Sharples' departure as CEO and appointed Fabrizio Mazzocchi as new CEO, effective January 9, 2023. Sharples, who co-founded the company in 1994, will support a smooth transition. Mazzocchi brings 30 years of healthcare experience, including over 20 years at Merck KGaA.PR NewswireColibrí™, COPAN's Automated Specimen Workup Instrument, Receives FDA 510(k) Clearance for use with bioMérieux VITEK® 2 Antimicrobial Susceptibility Testing (AST) SystemCOPAN Diagnostics Inc. announced FDA 510(k) clearance for its Colibrí™ automated specimen workup instrument to be used with bioMérieux's VITEK 2 Antimicrobial Susceptibility Testing system, marking the instrument's second regulatory clearance. Colibrí™ is the first instrument in its class to receive 510(k) clearance for simultaneous preparation of MALDI-TOF slides and McFarland AST suspensions, enabling full automation of culture workup for ID and AST. The system addresses clinical microbiology challenges including labor shortages and the need for rapid turnaround times by automating colony selection and transfer processes.PR NewswireCOPAN Diagnostics Unveils New Image in North AmericaCOPAN Diagnostics unveiled a new brand image at the ASM Microbe 2022 conference in Washington, DC, as part of its global rebranding. The company highlighted recent innovations including FDA clearance of Colibri, an automated colony picking instrument, and new AI software for bacterial culture interpretation.PR NewswireGlobal Medical Swabs Markets, 2022-2027 - 3D-Printed Swabs for Covid-19 Testing, Launch of Automated Medical Swabs, Rise in Prevalence of Infectious Disease & HAIS, Advances in Medical Swab TechnologyResearchAndMarkets.com published a global medical swabs market report projecting a compound annual growth rate (CAGR) of 7.64% during 2022-2027, driven by increasing diagnostic centers, rising healthcare-associated infections (HAIs), and technological advancements including 3D-printed and automated swabs. The report identifies key market players including Puritan, COPAN Diagnostics, Origin, and Becton Dickinson and Company, noting that 3D printing reduced swab costs by one-tenth. The analysis highlights opportunities in mass COVID-19 testing and nasal swab preferences, while identifying supply chain disruptions and poor healthcare infrastructure in low and middle-income countries as market restraints.GlobeNewswireThe medical swab market is expected to reach CAGR of 7.64% during the forecast period 2022–2027ReportLinker released a market research report projecting the global medical swab market to grow at a 7.64% CAGR from 2022 to 2027. Growth is driven by increased research labs, diagnostic centers, and technological advancements like 3D-printed and automated swabs. Key vendors include Puritan, COPAN Diagnostics, and Becton Dickinson.PR NewswireMedical Equipment Manufacturer MedSchenker Announces Distribution Agreement With COPAN to Compete Against Chinese Knockoff SwabsMedSchenker has launched a distribution partnership with COPAN Diagnostics to distribute COPAN's patented flocked swabs (FLOQSwabs®) in the United States. The partnership is positioned as a strategic move to compete against inferior Chinese knockoff flocked swabs that flooded the market during the COVID-19 pandemic, amid an ongoing USITC investigation into importation of unauthorized flocked swabs. COPAN has significantly expanded its manufacturing capacity, enabling customers to source higher-quality products from trusted suppliers rather than unverified alternatives.